Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open Label, Cross-over Feasibility Study for Heparin-free Hemodialysis With the Dialyzer With Endexo™ in End-Stage Renal Disease (ESRD) Subjects

NCT04511338 is registered in ClinicalTrials.gov with Fresenius Medical Care North America as lead sponsor.

NCT NCT04511338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04511338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open Label, Cross-over Feasibility Study for Heparin-free Hemodialysis With the Dialyzer With Endexo™ in End-Stage Renal Disease (ESRD) Subjects
Lead sponsor
Fresenius Medical Care North America
Phase
Not applicable
Overall status
Completed
Start date
November 2, 2020
Completion date
June 16, 2021
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, patient requiring heparin free dialysis treatments